Literature DB >> 10208873

Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique.

A Takahashi1, H Sasaki, S J Kim, T Kakizoe, N Miyao, T Sugimura, M Terada, T Tsukamoto.   

Abstract

To screen the receptor genes in renal cell carcinoma (RCC) associated with angiogenesis, we performed differential hybridization of the cDNA library of membrane-type protein tyrosine kinases (mPTKs). Three thousand plaques of a mPTKs-enriched cDNA library were screened with mPTKs mixture probes produced from hypervascular RCC tissues and RCC cell lines. Six different cDNA fragments of the PTK genes were isolated, and the sequence analysis showed that these represented cDNAs for TIE1, KDR, FMS, FGFR-4, JAK1 and HCK. Of these genes, the expression of TIE1, KDR, and FGFR-4 was studied in RCC tissue and cell lines by Northern blot analysis. We also investigated the expression of vascular endothelial growth factor (VEGF), placenta growth factor (PlGF) and their receptor FLT-1. In all the hypervascular RCC tissues, the amounts of mRNAs for KDR and FLT-1 were increased compared to adjacent normal tissues. The TIE1 and FGFR-4 genes were also overexpressed in most of the hypervascular RCC tissues, while no mRNA of KDR, FLT-1, or TIE1 could be detected in any of the four human RCC cell lines. The amounts of the VEGF and PlGF mRNAs were increased in hypervascular RCC tissues, while VEGF mRNA was detected in the four cell lines but PlGF mRNA was not. FGFR-4 mRNA was expressed in three of the four cell lines. These results suggest that KDR, FLT-1, PlGF and TIE1 mRNAs are present in the mesenchymal cells of RCC, while VEGF and FGFR-4 genes are expressed in RCC cells themselves in vivo. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208873     DOI: 10.1006/bbrc.1999.0465

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease.

Authors:  Lan Ma; Haifeng Zhang; Carrie Han; Danian Tong; Meiyan Zhang; Yi'an Yao; Yu Luo; Xuebo Liu
Journal:  DNA Cell Biol       Date:  2012-02-07       Impact factor: 3.311

2.  Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.

Authors:  Hao Chen; Dan-Ping Shen; Zi-Zhen Zhang; Jia-Hua Liu; Yan-Ying Shen; Xing-Zhi Ni
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 3.  Perspectives in drug development for metastatic renal cell cancer.

Authors:  Bristi Basu; Tim Eisen
Journal:  Target Oncol       Date:  2010-08-06       Impact factor: 4.493

4.  Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma.

Authors:  Zhanshan Cha; Yan Zang; Huijun Guo; Haihui Gu; Xiaohua Tu; Haihan Song; Baohua Qian
Journal:  Mol Biol Rep       Date:  2014-01-01       Impact factor: 2.316

5.  Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array.

Authors:  J M Boer; W K Huber; H Sültmann; F Wilmer; A von Heydebreck; S Haas; B Korn; B Gunawan; A Vente; L Füzesi; M Vingron; A Poustka
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

Review 6.  The role of angiogenesis in prostate and other urologic cancers: a review.

Authors:  J I Izawa; C P Dinney
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

7.  Tyrosine kinase expression profile in clear cell renal cell carcinoma.

Authors:  Turang E Behbahani; Claudia Thierse; Claudia Baumann; Daniel Holl; Patrick J Bastian; Alexander von Ruecker; Stefan C Müller; Jörg Ellinger; Stefan Hauser
Journal:  World J Urol       Date:  2011-10-04       Impact factor: 4.226

Review 8.  [Microarrays for the identification of molecular markers in the diagnosis and therapy of renal cell carcinomas].

Authors:  H Sültmann; A Poustka
Journal:  Urologe A       Date:  2006-03       Impact factor: 0.639

9.  Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer.

Authors:  Hideaki Murase; Mikito Inokuchi; Yoko Takagi; Keiji Kato; Kazuyuki Kojima; Kenichi Sugihara
Journal:  Mol Clin Oncol       Date:  2014-05-15

10.  Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study.

Authors:  Hongmei Nan; Abrar A Qureshi; David J Hunter; Jiali Han
Journal:  BMC Cancer       Date:  2009-06-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.